Australia Stock Exchange release from AROA BIOSURGERY : Appendix 4D and Half Year Report
24/11/2021 21:27
Australia Stock Exchange release from AROA BIOSURGERY ARX.AX : Appendix 4D and Half Year Report
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million